The Molecularisation of Security: Medical Countermeasures, Stockpiling and the Governance of Biological Threats (Routledge New Security Studies)

(4)
The Molecularisation of Security: Medical Countermeasures, Stockpiling and the Governance of Biological Threats (Routledge New Security Studies) image
ISBN-10:

036768361X

ISBN-13:

9780367683610

Edition: 1
Released: May 31, 2023
Publisher: Routledge
Format: Paperback, 188 pages
Related ISBN: 9780367683603

Description:

Book details unavailable.

Best prices to buy, sell, or rent ISBN 9780367683610




Frequently Asked Questions about The Molecularisation of Security: Medical Countermeasures, Stockpiling and the Governance of Biological Threats (Routledge New Security Studies)

You can buy the The Molecularisation of Security: Medical Countermeasures, Stockpiling and the Governance of Biological Threats (Routledge New Security Studies) book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $50.26 on Amazon and is available from 15 sellers at the moment.

If you’re interested in selling back the The Molecularisation of Security: Medical Countermeasures, Stockpiling and the Governance of Biological Threats (Routledge New Security Studies) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the The Molecularisation of Security: Medical Countermeasures, Stockpiling and the Governance of Biological Threats (Routledge New Security Studies) book, the best buyback offer comes from and is $ for the book in good condition.

The The Molecularisation of Security: Medical Countermeasures, Stockpiling and the Governance of Biological Threats (Routledge New Security Studies) book is in very low demand now as the rank for the book is 10,941,066 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.